Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers
https://www.nature.com/articles/s41594-020-00536-8
..."Thus, small-molecule drugs should ideally be targeted and delivered to the Golgi and ERGIC of host cells to maximally inhibit SARS-CoV-2 E’s channel activity 40."
Yeah,I don't understand all of this, but for those that do you might like to translate! i'm sure BIT would be all over any significant papers, as the Global Science community does much of their expensive research for them thanks to Covid-19.
